Global In Vitro ADME-Tox Market 2021 by Company, Regions, Type and Application, Forecast to 2026

Report ID: GIR2110110007 | Category: Medical Care | Pages: 100 | Format: PDF | Published Date: November 19,2021

Request Sample Enquiry before buying Ask For Discount

Single User-$3480.00 Multi User-$5220.00

Report Description
View Table of Contents

Report Summary

The In Vitro ADME-Tox market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

According to our latest research, the global In Vitro ADME-Tox size is estimated to be USD  million in 2026 from USD  million in 2020, with a change  % between 2020 and 2021. The global In Vitro ADME-Tox market size is expected to grow at a CAGR of  % for the next five years.

Market segmentation
In Vitro ADME-Tox market is split by Type and by Application. For the period 2016-2026, the growth among segments provide accurate calculations and forecasts for revenue by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.

Market segment by Type, covers
    Small Molecules
    Biologics

Market segment by Application, can be divided into
    Biopharmaceutical Companies
    Government and Academic Institutes
    Others

Market segment by players, this report covers
    Charles River
    Labcorp
    Envigo
    Curia
    Evotec
    Bioduro-Sundia
    Lonza
    WuXi AppTec
    IQVIA
    Tecan Group
    Pharmaron
    Shanghai Medicilon
    ChemPartner
    Joinn Laboratories
    RTI International
    Eurofins Scientific
    Aragen Life Sciences
    Sai Life Sciences

Market segment by regions, regional analysis covers
    North America (United States, Canada, and Mexico)
    Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
    Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia, and Rest of Asia-Pacific)
    South America (Brazil, Argentina, Rest of South America)
    Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)

The content of the study subjects, includes a total of 12 chapters:
Chapter 1, to describe In Vitro ADME-Tox product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top players of In Vitro ADME-Tox, with revenue, gross margin and global market share of In Vitro ADME-Tox from 2019 to 2021.
Chapter 3, the In Vitro ADME-Tox competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by type and application, with revenue and growth rate by type, application, from 2016 to 2026.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2016 to 2021.and In Vitro ADME-Tox market forecast, by regions, type and end user, with revenue, from 2021 to 2026.
Chapter 11 and 12, to describe In Vitro ADME-Tox research findings and conclusion, appendix and data source.

1 Market Overview
    1.1 Product Overview and Scope of In Vitro ADME-Tox
    1.2 Classification of In Vitro ADME-Tox by Type
        1.2.1 Overview: Global In Vitro ADME-Tox Market Size by Type: 2020 Versus 2021 Versus 2026
        1.2.2 Global In Vitro ADME-Tox Revenue Market Share by Type in 2020
        1.2.3 Small Molecules
        1.2.4 Biologics
    1.3 Global In Vitro ADME-Tox Market by End User
        1.3.1 Overview: Global In Vitro ADME-Tox Market Size by Application: 2020 Versus 2021 Versus 2026
        1.3.2 Biopharmaceutical Companies
        1.3.3 Government and Academic Institutes
        1.3.4 Others
    1.4 Global In Vitro ADME-Tox Market Size & Forecast
    1.5 Global In Vitro ADME-Tox Market Size and Forecast by Region
        1.5.1 Global In Vitro ADME-Tox Market Size by Region: 2016 VS 2021 VS 2026
        1.5.2 Global In Vitro ADME-Tox Market Size by Region, (2016-2021)
        1.5.3 North America In Vitro ADME-Tox Market Size and Prospect (2016-2026)
        1.5.4 Europe In Vitro ADME-Tox Market Size and Prospect (2016-2026)
        1.5.5 Asia-Pacific In Vitro ADME-Tox Market Size and Prospect (2016-2026)
        1.5.6 South America In Vitro ADME-Tox Market Size and Prospect (2016-2026)
        1.5.7 Middle East and Africa In Vitro ADME-Tox Market Size and Prospect (2016-2026)
    1.6 Market Drivers, Restraints and Trends
        1.6.1 In Vitro ADME-Tox Market Drivers
        1.6.2 In Vitro ADME-Tox Market Restraints
        1.6.3 In Vitro ADME-Tox Trends Analysis
2 Company Profiles
    2.1 Charles River
        2.1.1 Charles River Details
        2.1.2 Charles River Major Business
        2.1.3 Charles River In Vitro ADME-Tox Product and Solutions
        2.1.4 Charles River In Vitro ADME-Tox Revenue, Gross Margin and Market Share (2019-2021)
        2.1.5 Charles River Recent Developments and Future Plans
    2.2 Labcorp
        2.2.1 Labcorp Details
        2.2.2 Labcorp Major Business
        2.2.3 Labcorp In Vitro ADME-Tox Product and Solutions
        2.2.4 Labcorp In Vitro ADME-Tox Revenue, Gross Margin and Market Share (2019-2021)
        2.2.5 Labcorp Recent Developments and Future Plans
    2.3 Envigo
        2.3.1 Envigo Details
        2.3.2 Envigo Major Business
        2.3.3 Envigo In Vitro ADME-Tox Product and Solutions
        2.3.4 Envigo In Vitro ADME-Tox Revenue, Gross Margin and Market Share (2019-2021)
        2.3.5 Envigo Recent Developments and Future Plans
    2.4 Curia
        2.4.1 Curia Details
        2.4.2 Curia Major Business
        2.4.3 Curia In Vitro ADME-Tox Product and Solutions
        2.4.4 Curia In Vitro ADME-Tox Revenue, Gross Margin and Market Share (2019-2021)
        2.4.5 Curia Recent Developments and Future Plans
    2.5 Evotec
        2.5.1 Evotec Details
        2.5.2 Evotec Major Business
        2.5.3 Evotec In Vitro ADME-Tox Product and Solutions
        2.5.4 Evotec In Vitro ADME-Tox Revenue, Gross Margin and Market Share (2019-2021)
        2.5.5 Evotec Recent Developments and Future Plans
    2.6 Bioduro-Sundia
        2.6.1 Bioduro-Sundia Details
        2.6.2 Bioduro-Sundia Major Business
        2.6.3 Bioduro-Sundia In Vitro ADME-Tox Product and Solutions
        2.6.4 Bioduro-Sundia In Vitro ADME-Tox Revenue, Gross Margin and Market Share (2019-2021)
        2.6.5 Bioduro-Sundia Recent Developments and Future Plans
    2.7 Lonza
        2.7.1 Lonza Details
        2.7.2 Lonza Major Business
        2.7.3 Lonza In Vitro ADME-Tox Product and Solutions
        2.7.4 Lonza In Vitro ADME-Tox Revenue, Gross Margin and Market Share (2019-2021)
        2.7.5 Lonza Recent Developments and Future Plans
    2.8 WuXi AppTec
        2.8.1 WuXi AppTec Details
        2.8.2 WuXi AppTec Major Business
        2.8.3 WuXi AppTec In Vitro ADME-Tox Product and Solutions
        2.8.4 WuXi AppTec In Vitro ADME-Tox Revenue, Gross Margin and Market Share (2019-2021)
        2.8.5 WuXi AppTec Recent Developments and Future Plans
    2.9 IQVIA
        2.9.1 IQVIA Details
        2.9.2 IQVIA Major Business
        2.9.3 IQVIA In Vitro ADME-Tox Product and Solutions
        2.9.4 IQVIA In Vitro ADME-Tox Revenue, Gross Margin and Market Share (2019-2021)
        2.9.5 IQVIA Recent Developments and Future Plans
    2.10 Tecan Group 
        2.10.1 Tecan Group Details
        2.10.2 Tecan Group Major Business
        2.10.3 Tecan Group In Vitro ADME-Tox Product and Solutions
        2.10.4 Tecan Group In Vitro ADME-Tox Revenue, Gross Margin and Market Share (2019-2021)
        2.10.5 Tecan Group Recent Developments and Future Plans
    2.11 Pharmaron
        2.11.1 Pharmaron Details
        2.11.2 Pharmaron Major Business
        2.11.3 Pharmaron In Vitro ADME-Tox Product and Solutions
        2.11.4 Pharmaron In Vitro ADME-Tox Revenue, Gross Margin and Market Share (2019-2021)
        2.11.5 Pharmaron Recent Developments and Future Plans
    2.12 Shanghai Medicilon
        2.12.1 Shanghai Medicilon Details
        2.12.2 Shanghai Medicilon Major Business
        2.12.3 Shanghai Medicilon In Vitro ADME-Tox Product and Solutions
        2.12.4 Shanghai Medicilon In Vitro ADME-Tox Revenue, Gross Margin and Market Share (2019-2021)
        2.12.5 Shanghai Medicilon Recent Developments and Future Plans
    2.13 ChemPartner
        2.13.1 ChemPartner Details
        2.13.2 ChemPartner Major Business
        2.13.3 ChemPartner In Vitro ADME-Tox Product and Solutions
        2.13.4 ChemPartner In Vitro ADME-Tox Revenue, Gross Margin and Market Share (2019-2021)
        2.13.5 ChemPartner Recent Developments and Future Plans
    2.14 Joinn Laboratories
        2.14.1 Joinn Laboratories Details
        2.14.2 Joinn Laboratories Major Business
        2.14.3 Joinn Laboratories In Vitro ADME-Tox Product and Solutions
        2.14.4 Joinn Laboratories In Vitro ADME-Tox Revenue, Gross Margin and Market Share (2019-2021)
        2.14.5 Joinn Laboratories Recent Developments and Future Plans
    2.15 RTI International
        2.15.1 RTI International Details
        2.15.2 RTI International Major Business
        2.15.3 RTI International In Vitro ADME-Tox Product and Solutions
        2.15.4 RTI International In Vitro ADME-Tox Revenue, Gross Margin and Market Share (2019-2021)
        2.15.5 RTI International Recent Developments and Future Plans
    2.16 Eurofins Scientific
        2.16.1 Eurofins Scientific Details
        2.16.2 Eurofins Scientific Major Business
        2.16.3 Eurofins Scientific In Vitro ADME-Tox Product and Solutions
        2.16.4 Eurofins Scientific In Vitro ADME-Tox Revenue, Gross Margin and Market Share (2019-2021)
        2.16.5 Eurofins Scientific Recent Developments and Future Plans
    2.17 Aragen Life Sciences
        2.17.1 Aragen Life Sciences Details
        2.17.2 Aragen Life Sciences Major Business
        2.17.3 Aragen Life Sciences In Vitro ADME-Tox Product and Solutions
        2.17.4 Aragen Life Sciences In Vitro ADME-Tox Revenue, Gross Margin and Market Share (2019-2021)
        2.17.5 Aragen Life Sciences Recent Developments and Future Plans
    2.18 Sai Life Sciences
        2.18.1 Sai Life Sciences Details
        2.18.2 Sai Life Sciences Major Business
        2.18.3 Sai Life Sciences In Vitro ADME-Tox Product and Solutions
        2.18.4 Sai Life Sciences In Vitro ADME-Tox Revenue, Gross Margin and Market Share (2019-2021)
        2.18.5 Sai Life Sciences Recent Developments and Future Plans
3 Market Competition, by Players
    3.1 Global In Vitro ADME-Tox Revenue and Share by Players (2019-2021)
    3.2 Market Concentration Rate
        3.2.1 Top 3 In Vitro ADME-Tox Players Market Share
        3.2.2 Top 10 In Vitro ADME-Tox Players Market Share
        3.2.3 Market Competition Trend
    3.3 In Vitro ADME-Tox Players Head Office, Products and Services Provided
    3.4 Mergers & Acquisitions
    3.5 New Entrants and Expansion Plans
4 Market Size Segment by Type
    4.1 Global In Vitro ADME-Tox Revenue and Market Share by Type (2016-2021)
    4.2 Global In Vitro ADME-Tox Market Forecast by Type (2021-2026)
5 Market Size Segment by Application
    5.1 Global In Vitro ADME-Tox Revenue Market Share by Application (2016-2021)
    5.2 In Vitro ADME-Tox Market Forecast by Application (2021-2026)
6 North America by Country, by Type, and by Application
    6.1 North America In Vitro ADME-Tox Revenue by Type (2016-2026)
    6.2 North America In Vitro ADME-Tox Revenue by Application (2016-2026)
    6.3 North America In Vitro ADME-Tox Market Size by Country
        6.3.1 North America In Vitro ADME-Tox Revenue by Country (2016-2026)
        6.3.2 United States In Vitro ADME-Tox Market Size and Forecast (2016-2026)
        6.3.3 Canada In Vitro ADME-Tox Market Size and Forecast (2016-2026)
        6.3.4 Mexico In Vitro ADME-Tox Market Size and Forecast (2016-2026)
7 Europe by Country, by Type, and by Application
    7.1 Europe In Vitro ADME-Tox Revenue by Type (2016-2026)
    7.2 Europe In Vitro ADME-Tox Revenue by Application (2016-2026)
    7.3 Europe In Vitro ADME-Tox Market Size by Country
        7.3.1 Europe In Vitro ADME-Tox Revenue by Country (2016-2026)
        7.3.2 Germany In Vitro ADME-Tox Market Size and Forecast (2016-2026)
        7.3.3 France In Vitro ADME-Tox Market Size and Forecast (2016-2026)
        7.3.4 United Kingdom In Vitro ADME-Tox Market Size and Forecast (2016-2026)
        7.3.5 Russia In Vitro ADME-Tox Market Size and Forecast (2016-2026)
        7.3.6 Italy In Vitro ADME-Tox Market Size and Forecast (2016-2026)
8 Asia-Pacific by Region, by Type, and by Application
    8.1 Asia-Pacific In Vitro ADME-Tox Revenue by Type (2016-2026)
    8.2 Asia-Pacific In Vitro ADME-Tox Revenue by Application (2016-2026)
    8.3 Asia-Pacific In Vitro ADME-Tox Market Size by Region
        8.3.1 Asia-Pacific In Vitro ADME-Tox Revenue by Region (2016-2026)
        8.3.2 China In Vitro ADME-Tox Market Size and Forecast (2016-2026)
        8.3.3 Japan In Vitro ADME-Tox Market Size and Forecast (2016-2026)
        8.3.4 South Korea In Vitro ADME-Tox Market Size and Forecast (2016-2026)
        8.3.5 India In Vitro ADME-Tox Market Size and Forecast (2016-2026)
        8.3.6 Southeast Asia In Vitro ADME-Tox Market Size and Forecast (2016-2026)
        8.3.7 Australia In Vitro ADME-Tox Market Size and Forecast (2016-2026)
9 South America by Country, by Type, and by Application
    9.1 South America In Vitro ADME-Tox Revenue by Type (2016-2026)
    9.2 South America In Vitro ADME-Tox Revenue by Application (2016-2026)
    9.3 South America In Vitro ADME-Tox Market Size by Country
        9.3.1 South America In Vitro ADME-Tox Revenue by Country (2016-2026)
        9.3.2 Brazil In Vitro ADME-Tox Market Size and Forecast (2016-2026)
        9.3.3 Argentina In Vitro ADME-Tox Market Size and Forecast (2016-2026)
10 Middle East & Africa by Country, by Type, and by Application
    10.1 Middle East & Africa In Vitro ADME-Tox Revenue by Type (2016-2026)
    10.2 Middle East & Africa In Vitro ADME-Tox Revenue by Application (2016-2026)
    10.3 Middle East & Africa In Vitro ADME-Tox Market Size by Country
        10.3.1 Middle East & Africa In Vitro ADME-Tox Revenue by Country (2016-2026)
        10.3.2 Turkey In Vitro ADME-Tox Market Size and Forecast (2016-2026)
        10.3.3 Saudi Arabia In Vitro ADME-Tox Market Size and Forecast (2016-2026)
        10.3.4 UAE In Vitro ADME-Tox Market Size and Forecast (2016-2026)
11 Research Findings and Conclusion
12 Appendix
    12.1 Methodology
    12.2 Research Process and Data Source
    12.3 Disclaimer

FAQ's

What does the report cover (Scope)?

It contains all the geographic trends, and market analysis for global market

ENTER REPORT NAME TO SEARCH

Global In Vitro ADME-Tox Market 2021 by Company, Regions, Type and Application, Forecast to 2026

Report Summary

Table of Contents

FAQ's

What does the report cover (Scope)?